Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for painless induced abortion
ChiCTR2000037495Phase 3Not yet recruiting
- Sponsor
- Jingzhou First People's Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remimazolam in Induced Abortion (TOP) (2 arms), sponsored by Jingzhou First People's Hospital. Primary endpoints: Hemodynamic and respiratory parameters and BIS from start of administration until end of operation and stabilization, MOAA/S score during operation and 3 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on ChiCTR2000037495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037495.